DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? reply

Author(s):
Henricks, L.M. (0000-0003-0141-7927); Lunenburg, C.A.T.C. (0000-0003-0173-9803); Cats, A.; Mathijssen, R.H.J.; Guchelaar, H.J. (0000-0002-7085-1383); Schellens, J.H.M.
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-02-28
Language
English
Is part of
The Lancet Oncology (2019), Vol. 20, no. 2, p. E67-E67
hdl
1887/120020